Ketamine use: a review

被引:456
作者
Morgan, Celia J. A. [1 ]
Curran, H. Valerie [1 ]
机构
[1] UCL, Clin Psychopharmacol Unit, London WC1E 6BT, England
关键词
Addiction; chronic; cognitive; dependence; harms; ketamine; neurological; physical harms; social harms; ulcerative cystitis; EMISSION-TOMOGRAPHY PET; D-ASPARTATE ANTAGONISTS; COMMON BILE-DUCTS; HEALTHY-VOLUNTEERS; K-HOLE; SUBANESTHETIC KETAMINE; ULCERATIVE CYSTITIS; REPEATED ANESTHESIA; PREFRONTAL CORTEX; CLINICAL ENTITY;
D O I
10.1111/j.1360-0443.2011.03576.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims Ketamine remains an important medicine in both specialist anaesthesia and aspects of pain management. At the same time, its use as a recreational drug has spread in many parts of the world during the past few years. There are now increasing concerns about the harmful physical and psychological consequences of repeated misuse of this drug. The aim of this review was to survey and integrate the research literature on physical, psychological and social harms of both acute and chronic ketamine use. Method The literature on ketamine was systematically searched and findings were classified into the matrix of Nutt et al.'s (2007) rational scale for assessing the harms of psychoactive substances. Results A major physical harm is ketamine induced ulcerative cystitis which, although its aetiology is unclear, seems particularly associated with chronic, frequent use of the drug. Frequent, daily use is also associated with neurocognitive impairment and, most robustly, deficits in working and episodic memory. Recent studies suggest certain neurological abnormalities which may underpin these cognitive effects. Many frequent users are concerned about addiction and report trying but failing to stop using ketamine. Conclusions The implications of these findings are drawn out for treatment of ketamine-induced ulcerative cystitis in which interventions from urologists and from addiction specialists should be coordinated. Neurocognitive impairment in frequent users can impact negatively upon achievement in education and at work, and also compound addiction problems. Prevention and harm minimization campaigns are needed to alert young people to these harmful and potentially chronic effects of ketamine.
引用
收藏
页码:27 / 38
页数:12
相关论文
共 106 条
  • [1] Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
    aan het Rot, Marije
    Collins, Katherine A.
    Murrough, James W.
    Perez, Andrew M.
    Reich, David L.
    Charney, Dennis S.
    Mathew, Sanjay J.
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (02) : 139 - 145
  • [2] Abdel-Rahman MS, 2000, TERATOLOGY, V61, P291, DOI 10.1002/(SICI)1096-9926(200004)61:4<291::AID-TERA8>3.3.CO
  • [3] 2-H
  • [4] Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials
    Amann, Laura C.
    Halene, Tobias B.
    Ehrlichman, Richard S.
    Luminais, Stephen N.
    Ma, Nan
    Abel, Ted
    Siegel, Steven J.
    [J]. NEUROBIOLOGY OF DISEASE, 2009, 35 (02) : 311 - 317
  • [5] [Anonymous], 2010, MONITORING FUTURE NA
  • [6] [Anonymous], 2010, World drug report 2010 (tech. rep.)
  • [7] [Anonymous], 2010, MIXMAG
  • [8] Pharmacological Aspects and Potential New Clinical Applications of Ketamine: Reevaluation of an Old Drug
    Aroni, Filippia
    Iacovidou, Nicoletta
    Dontas, Ismene
    Pourzitaki, Chryssa
    Xanthos, Theodoros
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (08) : 957 - 964
  • [9] Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia
    Becker, A
    Peters, B
    Schroeder, H
    Mann, T
    Huether, G
    Grecksch, G
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (04) : 687 - 700
  • [10] Intravenous midazolam significantly enhances the lethal effect of thiopental but not that of ketamine in mice
    Ben-Shlomo, I
    Rosenbaum, A
    Hadash, O
    Katz, Y
    [J]. PHARMACOLOGICAL RESEARCH, 2001, 44 (06) : 509 - 512